SCHEMBL6020396

SCHEMBL6020396

N#CCCNS(=O)(=O)c1ccccc1OC(F)(F)F

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A12 Q96S37 4/20 0.52
TRPV4 Q9HBA0 2/20 0.52
CCR1 P32246 1/20 0.46
ALPL P05186 1/20 0.44
PDE4A P27815 1/20 0.44
PDE4B Q07343 1/20 0.44
PDE4C Q08493 1/20 0.44
PDE4D Q08499 1/20 0.44
PARG Q86W56 1/20 0.44
SLC40A1 Q9NP59 1/20 0.44
ALOX5AP P20292 2/20 0.43
FEN1 P39748 2/20 0.43
BRD4 O60885 1/20 0.39
NAMPT P43490 1/20 0.38
ADRB1 P08588 1/20 0.38
KDM4E B2RXH2 1/20 0.37
MAPT P10636 1/20 0.37
ATM Q13315 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
CNR1 P21554 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3688266 0.82 CA12 (0.51) SLC22A12TRPV4CCR1ALPLSLC40A1
SCHEMBL27502184 0.80 CA12 (0.53) SLC22A12TRPV4CCR1ALPLSLC40A1
SCHEMBL6020640 0.79 SLC22A12 (0.57) SLC22A12TRPV4PARG
SCHEMBL12491364 0.76 SMN1; SMN2 (0.54) SLC22A12ALPLSLC40A1
SCHEMBL6021145 0.76 PDE4A (0.53) CCR1PDE4APDE4BPDE4CPDE4D
SCHEMBL4074736 0.76 SLC22A12 (0.49) SLC22A12TRPV4ALPLSLC40A1BRD4
SCHEMBL15621236 0.75 ALPL (0.49) SLC22A12TRPV4CCR1ALPLSLC40A1
SCHEMBL16934403 0.75 ALPL (0.46) SLC22A12TRPV4CCR1ALPLSLC40A1
SCHEMBL27999788 0.75 ALPL (0.53) SLC22A12TRPV4CCR1ALPLSLC40A1
SCHEMBL6020272 0.74 RECQL (0.57) CCR1PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060252813-A1 Apparatus for curing a composite laminate JERINI AG (DE) 2006-11-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060252813-A1 Apparatus for curing a composite laminate DHX29, HDHD5, DHRS9 SLC22A12 4607/4885TRPV4 4188/4885CCR1 760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.